In a similar way, miR-145 from AD-MSC derived EVs could extend the inhibitory effects of MSCs on prostate cancer by blocking the activities Bclxl protein, followed by increased cell apoptosis of prostate cancer cells [148]. This evidence concerns the gene BCL2L1 and prostate carcinoma.